BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25092176)

  • 21. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX11, CD70, and Treg cells configure the tumor-immune microenvironment of aggressive mantle cell lymphoma.
    Balsas P; Veloza L; Clot G; Sureda-Gómez M; Rodríguez ML; Masaoutis C; Frigola G; Navarro A; Beà S; Nadeu F; Giné E; López-Guillermo A; Martínez A; Ribera-Cortada I; Engel P; Quintanilla-Martínez L; Klapper W; Campo E; Amador V
    Blood; 2021 Dec; 138(22):2202-2215. PubMed ID: 34189576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of SOX11 immunohistochemistry in differentiating cutaneous spread of mantle cell lymphoma from primary cutaneous B-cell lymphomas.
    Hsi AC; Hurley MY; Lee SJ; Rosman IS; Pang X; Gru A; Schaffer A
    J Cutan Pathol; 2016 Apr; 43(4):354-61. PubMed ID: 26762898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
    Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S
    Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
    Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
    Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX11 and HIG-2 are cross-regulated and affect growth in mantle cell lymphoma.
    Kuci V; Nordström L; Conrotto P; Ek S
    Leuk Lymphoma; 2016 Aug; 57(8):1883-92. PubMed ID: 26757780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis.
    Lee W; Shin E; Kim BH; Kim H
    PLoS One; 2019; 14(11):e0225096. PubMed ID: 31714947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
    Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
    Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival.
    Wang X; Asplund AC; Porwit A; Flygare J; Smith CI; Christensson B; Sander B
    Br J Haematol; 2008 Oct; 143(2):248-52. PubMed ID: 18729857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo growth of mantle cell lymphoma xenografts in immunodeficient mice is positively regulated by VEGF and associated with significant up-regulation of CD31/PECAM1.
    Molinský J; Klánová M; Maswabi B; Soukup T; Trněný M; Nečas E; Živný J; Klener P
    Folia Biol (Praha); 2013; 59(1):26-31. PubMed ID: 23537525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX11 expression in mantle cell lymphoma.
    Xu W; Li JY
    Leuk Lymphoma; 2010 Nov; 51(11):1962-7. PubMed ID: 20919851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8.
    Huang J; Ji EH; Zhao X; Cui L; Misuno K; Guo M; Huang Z; Chen X; Hu S
    J Exp Clin Cancer Res; 2019 Mar; 38(1):138. PubMed ID: 30922366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
    Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
    Blood; 2024 Jan; 143(19):1953-1964. PubMed ID: 38774451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
    Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of myocyte enhancer factor 2B in mantle cell lymphoma and its clinical significance].
    Liu F; Liu Q; Guo N; Zhang GM; Deng YF; Hu WW; Rao HL
    Zhonghua Bing Li Xue Za Zhi; 2020 Jan; 49(1):40-46. PubMed ID: 31914533
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype.
    Ribera-Cortada I; Martinez D; Amador V; Royo C; Navarro A; Beà S; Gine E; de Leval L; Serrano S; Wotherspoon A; Colomer D; Martinez A; Campo E
    Mod Pathol; 2015 Nov; 28(11):1435-47. PubMed ID: 26360498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma.
    Roisman A; Huamán Garaicoa F; Metrebian F; Narbaitz M; Kohan D; García Rivello H; Fernandez I; Pavlovsky A; Pavlovsky M; Hernández L; Slavutsky I
    Genes Chromosomes Cancer; 2016 Jun; 55(6):531-40. PubMed ID: 26998831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.